Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Central nervous system and systemic vasculitides].

L Guillevin1, J Ramanoelina, A Mahr

  • 1Hôpital Avicenne, Assistance Publique des Hôpitaux de Paris, UPRES 3409 Recherche clinique et thérapeuthique , Université Paris-Nord, Bobigny, France.

Revue Neurologique
|October 31, 2002
PubMed
Summary

Central nervous system vasculitis affects less than 10% of systemic vasculitis cases. Early diagnosis and treatment with steroids and cyclophosphamide improve outcomes for this severe condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence of and mortality from epidermal necrolysis (Stevens-Johnson syndrome/toxic epidermal necrolysis) in France during 2003-16: a four-source capture-recapture estimate.

The British journal of dermatology·2019
Same author

[Epidemiology and natural history of giant cell arteritis].

La Revue de medecine interne·2017
Same author

EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis.

Annals of the rheumatic diseases·2016
Same author

Management of giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA).

La Revue de medecine interne·2016
Same author

[Epidemiology of Behçet's disease].

La Revue de medecine interne·2014
Same author

[Prolonged fever in a 62-year-old man].

La Revue de medecine interne·2013

Area of Science:

  • Neurology
  • Rheumatology
  • Immunology

Context:

  • Central nervous system (CNS) involvement is a rare but serious complication of systemic vasculitides, affecting large, medium, or small vessels.
  • Symptoms are diverse, stemming from vasculitis, hypertension, thrombosis, or embolism, and can manifest initially, during relapse, or as treatment side effects.
  • Primary CNS vasculitis, a rare granulomatous form, presents diagnostic challenges.

Purpose:

  • To review the clinical presentation, diagnosis, and prognosis of CNS vasculitis.
  • To highlight the diagnostic difficulties and the importance of clinical symptoms combined with brain imaging.
  • To discuss treatment strategies and their impact on patient outcomes.

Summary:

  • CNS vasculitis occurs in <10% of systemic vasculitis cases, presenting heterogeneously.

Related Experiment Videos

  • Diagnosis relies on histology, clinical symptoms, and brain imaging; primary CNS vasculitis is rare and challenging to diagnose.
  • Cognitive impairments can occur but may improve with treatment; prognosis is severe, with mortality linked to the Five Factor Score.

    • Impact:

    • CNS vasculitis significantly impacts patient prognosis, with mortality rates increasing with higher Five Factor Scores.
    • Effective treatment, typically a combination of steroids and cyclophosphamide, is crucial for improving outcomes.
    • Understanding CNS vasculitis is vital for timely diagnosis and management, potentially reducing severe morbidity and mortality.